| AstraZeneca AG - Calquence 100 mg, Hartkapseln | | 67790 | | 01 | | Calquence 100 mg | | Hartkapseln | | L01EL02 | | Acalabrutinib | | 04.03.2021 | | |
| | Composition | | acalabrutinibum 100 mg, cellulosum microcristallinum silicificatum, amylum pregelificatum, carboxymethylamylum natricum A corresp. natrium max. 0.25 mg, magnesii stearas, Kapselhülle: gelatina, E 172 (flavum), E 132, E 171, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammonii hydroxidum, pro capsula. | | Packungsbestandteile | | Capsules | | | | | Principe actif | Concentr. |
|---|
| Acalabrutinibum | 100 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Acalabrutinibum | 100 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| (Flavum) | | | | (Nigrum) | | | | Ammonii Hydroxidum | | | | Amylum Pregelificatum | | | | Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum Silicificatum | | | | E 132 | | color. | | E 171 | | color. | | E 172 | | color. | | Gelatina | | Kapselhülle | | Lacca | | Drucktinte | | Magnesii Stearas | | | | Pro Capsula | | | | Propylenglycol | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 60 | 4526.77 | 4939.55 | A | LS | Oui |
|
|
